Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kineta Inc KA

Healthcare Biotechnology
Kineta, Inc. is a clinical-stage biotechnology company. The Company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance: immunosuppression, exhausted T cells and poor tumor immunogenicity. Its pipeline of immunotherapies includes KVA12123, which is a... see more

Recent & Breaking News (NDAQ:KA)

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire October 4, 2023

Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial

GlobeNewswire October 3, 2023

Kineta Announces Participation at October Investor Conferences

GlobeNewswire September 28, 2023

Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy

GlobeNewswire September 25, 2023

Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression

GlobeNewswire September 18, 2023

Kineta to Participate in Upcoming Investor Conferences

GlobeNewswire August 31, 2023

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 11, 2023

Kineta to Receive $5 Million Milestone Payment from Merck

GlobeNewswire June 29, 2023

Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla

GlobeNewswire June 28, 2023

Kineta Set to Join Russell Microcap® Index

GlobeNewswire May 24, 2023

Kineta to Present at Jefferies Healthcare Conference

GlobeNewswire May 23, 2023

Kineta Reports First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 11, 2023

Kineta, Inc. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire April 24, 2023

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire April 20, 2023

Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023

GlobeNewswire April 17, 2023

Kineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors

GlobeNewswire April 12, 2023

Kineta to Present at 22nd Annual Needham Healthcare Conference

GlobeNewswire April 3, 2023

Kineta Reports Full Year 2022 Financial Results and Provides Corporate Update

GlobeNewswire March 31, 2023

Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023

GlobeNewswire March 22, 2023

Kineta to Present at the Oppenheimer 33rd Annual Healthcare Conference

GlobeNewswire March 8, 2023